Thromboembolic Events, Anticoagulation, and COVID-19: Preemptive Treatments and Risks After Vaccination

Preemptive anticoagulation for post-acute and long-term care residents infected with SARS-CoV-2 is worth consideration, given that venous thromboembolism (VTE) is not uncommon in COVID-19 and most PALTC residents have a higher risk for VTE to begin with, said Nadia Mujahid, MD, CMD, at the Annual Conference of AMDA – The Society for Post-Acute and Long-Term Care Medicine during a session on antithrombotic treatments for residents with SARS CoV-2/COVID-19. “Let’s not wait for residents to develop a VTE.